albumina grifols
instituto grifols s.a. - albumina - albumina
albumina umana grifols
instituto grifols s.a. - albumina - albumina
plasbumin
instituto grifols s.a. - albumina - albumina
igantet
instituto grifols s.a. - immunoglobulina tetanica - immunoglobulina tetanica
igamad
instituto grifols s.a. - immunoglobulina anti-d (rh) - immunoglobulina anti-d (rh)
anbinex
instituto grifols s.a. - antitrombina iii - antitrombina iii
igantibe
instituto grifols s.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
prolastin
instituto grifols s.a. - alfa1 antitripsina - alfa1 antitripsina
niuliva
instituto grifols s.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - l'immunoglobulina umana normale - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - sieri immuni e immunoglobuline, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.